Journal Guide

Written and edited by renowned professionals, each biweekly issue of Circulation Research explores some of the most revolutionary research from areas like cellular therapy, arrhythmias, nuclear mechanotransduction, gene therapy, stem cells and more.Online subscriptions are available to members of the American Heart Association/American Stroke Association as a benefit of membership depending on membership level. Members may also qualify for special rates on print subscriptions. Visit My.AmericanHeart.org for more information on membership benefits and to join/renew today!Ranked 2nd in Peripheral Vascular Disease and 3rd in Cardiac & Cardiovascular Systems and Hematology Subject Matter Categories (2008 Journal Citation Reports174;, Thomson Reuters, 2009).

Circulation: Arrhythmia and Electrophysiology publishes high-quality, clinically relevant articles focusing on advances in the understanding of the pathophysiology, diagnosis, and treatment of cardiac arrhythmias. This new journal reflects the rapid evolution of cardiac electrophysiology as a discipline in its own right. Circulation: Arrhythmia and Electrophysiology presents critical new research on topics related to clinical applications such as devices for arrhythmia management, catheter ablation, the pathophysiology of the arrhythmia substrate, and novel biologic therapies. Commentaries and reviews on topics of special interest, editorials and opinion pieces, and other special features provide a worldwide forum for all professionals in the field. American Heart Association Premium Professional Members receive online access to all 6 new AHA Circulation Portfolio of Journals through December 31, 2008. Premium Professional Members also qualify for special rates on print subscriptions. Early Career and Student/Trainee members are eligible for special rates on print subscriptions, or for a nominal fee can access all 11 AHA Scientific Journals online. General Professional Members pay the Non-Member Individual rate.

Circulation: Cardiovascular Imaging publishes high-quality, patient-centric articles focusing onobservational studies, clinical trials, and advances in applied (translational) research featuring innovative, multimodality approaches to diagnosis and risk stratifications of cardiovascular disease. Modalities covered include echocardiography, cardiac computed tomography, cardiac magnetic resonance imaging and spectroscopy, magnetic resonance angiography, cardiac positron emission tomography, noninvasive assessment of vascular and endothelial function, radionuclide imaging, molecular imaging, and others. In addition to original articles, robust review series will feature clinically relevant, disease-based reviews on current applications of imaging. The series features novel imaging technologies and their potential clinical role, reviews on methodological and analytical issues affecting imaging-based research, as well as translational aspects of molecularly targeted imaging research.American Heart Association Premium Professional Members receive online access to all 6 new AHA Circulation Portfolio of Journals through December 31, 2008. Premium Professional Members also qualify for special rates on print subscriptions. Early Career and Student/Trainee members are eligible for special rates on print subscriptions, or for a nominal fee can access all 11 AHA Scientific Journals online. General Professional Members pay the Non-Member Individual rate.

Circulation: Cardiovascular Interventions focuses on interventional techniques pertaining to coronary artery disease, structural heart disease, and vascular disease, with priority placed on original research and on randomized trials and large registry studies that will significantly advance your practice and your patients' outcomes. In addition, pharmacological, diagnostic, and pathophysiological aspects of interventional cardiology will be given special attention.Circulation: Cardiovascular Interventions will be complemented by special sections such as letters to the editor, imaging case reports, and additional features, providing a worldwide forum for all professionals interested in the study and application of interventional therapies.AHA/ASA Premium Professional Members receive online access to all 6 new AHA Circulation Portfolio of Journals through December 31, 2008. Premium Professional Members also qualify for special rates on print subscriptions. Early Career and Student/Trainee members are eligible for special rates on print subscriptions, or for a nominal fee can access all 11 AHA Scientific Journals online. General Professional Members pay the Non-Member Individual rate.

Cirugía Cardiovascular es el órgano oficial de la Sociedad Española de Cirugía Torácica y Cardiovascular (SECTCV) y actúa como herramienta de expresión de todos los cirujanos torácicos y cardiovasculares de habla hispana. La misión de la Sociedad Española de Cirugía Torácica y Cardiovascular es asegurar la calidad en el ejercicio de las cirugías torácica y cardiovascular mediante la formación, la promoción de la investigación, el desarrollo y difusión de estándares y guías, y su influencia sobre las políticas sanitarias a nivel nacional.

Cirugía Española, es el Órgano Oficial de la Asociación Española de Cirujanos, sociedad científica que engloba a la mayoría de cirujanos generales españoles y de diferentes subespecialidades de la cirugía.
La revista es el mejor exponente del desarrollo técnico y conceptual de la cirugía española, de tal manera, que en sus páginas se dedica una creciente atención a los aspectos biológicos y clínicos de la patología quirúrgica, trascendiendo así al acto operatorio que en constituía el centro de atención principal de esta área de la medicina.
Los contenidos de la revista se estructura en las secciones de Originales, Revisiones, Cartas Científicas, Imagen del Mes y Cartas al director, y los artículos se seleccionan y publican tras un riguroso análisis, siguiendo los estándares internacionalmente aceptados. Cirugía Española cuenta desde 2008 con una versión en inglés.

La revista Cirugía y Cirujanos es el órgano de difusión científica de la Academia Mexicana de Cirugía, institución fundada en 1933, órgano consultivo del Gobierno Federal en materia de salud y política social y asesor del Consejo de Salubridad General de México. Su membresía es de 421 destacados profesionistas de 64 especialidades médicas, quirúrgicas y de profesionistas de áreas afines a la salud, lo cual ha contribuido a dar cuerpo, estructura, doctrina, misión, visión y prestigio a la cirugía y a la medicina mexicana en el contexto internacional.

Cirugía y Cirujanos es exponente del desarrollo académico, científico, médico, quirúrgico y tecnológico en materia de salud en México y en el ámbito internacional. Se editan en forma bimestral en inglés y en español artículos científicos originales, casos clínicos, artículos de revisión de interés general y cartas al editor. Los artículos se seleccionan y publican siguiendo un riguroso análisis, de acuerdo a los estándares internacionalmente aceptados.

To publish debates, analyses, and results of research on a Specific Theme considered current and relevant to the field of Collective Health.

Climacteric – publishes international, original, peer-reviewed research on all aspects of aging in men and women, especially during the menopause and climacteric. The content of the journal covers the whole range of subject areas relevant to climacteric studies and adult women’s health and medicine, including underlying endocrinological changes, treatment of the symptoms of the menopause and other age-related changes, hormone replacement therapies, alternative therapies, effective life-style modifications, non-hormonal midlife changes, and the counselling and education of perimenopausal and postmenopausal patients. In addition, the journal features regular invited expert editorials, a correspondence section and details of forthcoming international meetings on climacteric-related topics. All material is subject to peer review by members of the editorial board, and a specialist reviewer where indicated.

6 NÚMEROS AL AÑO + EXTRAORDINARIO CONGRESO

Para más información, consulte http://www.elsevier.es/arterio

The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/506018/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field. In response to the increasing number of quality submissions, since 1996 the journals size has increased by over 30%. Clinical & Experimental Allergy is essential reading for allergy practitioners and research scientists with an interest in allergic diseases and mechanisms. Truly international in appeal, Clinical & Experimental Allergy publishes clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part. Clinical & Experimental Allergy Reviews is a supplement series publishing the edited proceedings of international meetings and sponsored symposia, position papers, guidelines, special reports, and so on. It is allied to Clinical & Experimental Allergy and included with every subscription to the primary research journal.

Clinical & Experimental Immunology is a top ranking, international journal publishing biologically significant studies that have clinical relevance. The Journal is focused on Translational Immunology and is amongst the foremost journals in this field, attracting high-quality papers from all parts of the world. Translation is viewed as a process of applying ideas, insights and discoveries generated through basic scientific studies to the treatment, prevention or diagnosis of human disease. Journal articles cover clinical studies in patients receiving immune-based therapies, in relation to autoimmunity, primary and secondary immunodeficiencies, complement disorders and allergies. The Journal also reports investigations on the pathogenesis of rheumatic, renal and endocrine disorders, as well as infectious diseases, malignancy and transplantation. Basic immunology studies that inform clinical practice or understanding of disease mechanisms are also welcomed, as are studies in non-human model systems and reports on the physiological mechanisms of immunity. In addition to research reports, the Journal publishes highly cited review, perspective and hypothesis articles. These are usually commissioned and published as Translational Mini-Review series, but suggestions to the Editor-in-Chief of topics for such series, or titles for one-off review articles are welcome. The Journal encourages submission of articles that represent position papers on the classification, diagnosis or treatment of immunological disease.Articles deemed to be of potentially high impact may be drawn to the attention of the Editorial Team for allocation to our Fast-Track category, enabling papers of immediate interest to reach their audience as quickly as possible.Free Access in the Developing WorldFree online access to this journal is available within institutions in the developing world through the HINARI initiative with the World Health Organization (WHO).Online OpenAuthors of articles in this journal can now choose to make their articles open access and available free for all readers through the payment of an author fee.

Clinical & Experimental Ophthalmology is the official journal of The Royal Australian and New Zealand College of Ophthalmologists. The journal primarily publishes peer-reviewed original research and reviews dealing with all aspects of clinical practice and research in ophthalmology and vision science. Short articles are also welcomed for publication under the headings 'Clinicopathological Report', 'Clinical and Surgical Techniques', 'History of Ophthalmology' and 'Letters to the Editor'. Manuscripts dealing with 'Ophthalmic Hypothesis', and 'Developing World Ophthalmology' are encouraged. Reports of interesting and original cases may be published as 'Photographic Essays' or 'Clinical Case Notes' in Letters to the Editor. The acceptance criteria for all papers are the quality, originality and significance of the research. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers, a Section Editor and the Editor in an average time of 2.5 months. The average time from original submission to publication, for manuscripts that are accepted, is 10 months. The Editorial Board reserves the right to refuse any material for publication and advises that authors should retain copies of submitted manuscripts, figures and correspondence, as material cannot be returned. Final acceptance or rejection rests with the Editorial Board.

Each issue of Clinical Reviews in Bone and Mineral Metabolism is devoted to a single theme aimed at integrating new information, both basic and clinical science, into the context of clinical practice. For each review article, there is an interval of 6-9 months between invitation to authors and publication. Each issue features guest editors recognized for their own contributions to the field, thereby ensuring that the right colleagues have been invited to review the most current information.